Fibrinolytic activity and coronary-artery disease.

Suppr

超能文献

作者信息

Chakrabarti R, Hocking E D, Fearnley G R, Mann R D, Attwell T N, Jackson D

出版信息

Lancet. 1968 May 11;1(7550):987-90. doi: 10.1016/s0140-6736(68)91104-5.

DOI:10.1016/s0140-6736(68)91104-5

PMID:4171834

Abstract

摘要

相似文献

Fibrinolytic activity and coronary-artery disease.

Lancet. 1968 May 11;1(7550):987-90. doi: 10.1016/s0140-6736(68)91104-5.

[Hypofibrinolysis in acute myocardial infarction (author's transl)].急性心肌梗死中的低纤维蛋白溶解（作者译）

Med Klin. 1974 Nov 22;69(47):1951-5.

Fibrinolytic activity and coronary-artery disease.纤溶活性与冠状动脉疾病

Lancet. 1968 May 11;1(7550):1017-8.

Fibrinolytic activity and postoperative deep-vein thrombosis.纤溶活性与术后深静脉血栓形成

Lancet. 1974 Jan 5;1(7845):9-11. doi: 10.1016/s0140-6736(74)93000-1.

Pharmacological stimulation of fibrinolytic activity in the surgical patient.

Lancet. 1971 Apr 17;1(7703):774-6. doi: 10.1016/s0140-6736(71)91215-3.

Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.苯乙双胍加乙基雌烯醇用于心肌梗死幸存者：三年试点研究

Lancet. 1972 Sep 16;2(7777):556-9. doi: 10.1016/s0140-6736(72)91956-3.

Letter: Fibrinolytic activity and postoperative deep-vein thrombosis.信函：纤维蛋白溶解活性与术后深静脉血栓形成

Lancet. 1974 May 4;1(7862):868. doi: 10.1016/s0140-6736(74)90518-2.

Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.苯乙双胍与乙基雌烯醇联合治疗对凝血和纤溶系统的影响。

J Clin Pathol. 1972 Jul;25(7):638-9. doi: 10.1136/jcp.25.7.638.

Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.皮肤血管炎患者纤溶治疗效果的临床与实验室双盲研究

Br Med J. 1973 Apr 14;2(5858):82-4. doi: 10.1136/bmj.2.5858.82.

[Hyperfibrinogemia following activator therapy].[激活剂治疗后高纤维蛋白原血症]

Acta Haematol Pol. 1972 Jan-Mar;3(1):53-8.

引用本文的文献

Prevention and Treatment of Thrombosis.血栓形成的预防与治疗

J R Coll Physicians Lond. 1969 Jan;3(2):171-181.

Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.无需辅助抗栓治疗实现最佳再灌注：新型溶栓给药策略

J Thromb Thrombolysis. 1995;1(3):269-277. doi: 10.1007/BF01060736.

High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.冠心病患者中纤溶酶原激活物抑制物活性较高，与甘油三酯和高密度脂蛋白胆固醇值相关，心肌梗死幸存者之间无差异。

Ann Hematol. 1993 Nov;67(5):237-44. doi: 10.1007/BF01715054.

Hypercoagulability and coronary artery disease.

Br Heart J. 1984 Dec;52(6):614-6. doi: 10.1136/hrt.52.6.614.

Pharmacological enhancement of fibrinolysis.纤维蛋白溶解的药理学增强。

J Clin Pathol. 1969 May;22(3):368-9. doi: 10.1136/jcp.22.3.368-b.

Oral fibrinolytic agents.口服纤维蛋白溶解剂。

Br Med J. 1968 Aug 24;3(5616):498. doi: 10.1136/bmj.3.5616.498-a.

Serum lipids, typing, fibrinolysis, and smoking.血脂、血型、纤维蛋白溶解与吸烟。

Br Med J. 1970 Jul 25;3(5716):223. doi: 10.1136/bmj.3.5716.223-a.

Fibrinolysis in cutaneous vasculitis.皮肤血管炎中的纤维蛋白溶解

Proc R Soc Med. 1971 Sep;64(9):928. doi: 10.1177/003591577106400922.

The fibrinolytic system.纤溶系统

Proc R Soc Med. 1971 Sep;64(9):923-5. doi: 10.1177/003591577106400919.

Levels of soluble fibrin monomer complexes in the course of myocardial infarction.心肌梗死过程中可溶性纤维蛋白单体复合物的水平。

Br Heart J. 1972 Jun;34(6):593-6. doi: 10.1136/hrt.34.6.593.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验